Wenlei Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wenlei Wu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Chao Liu
Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, China
1 shared publicationChenying Shen
Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, China
1 shared publicationJie Yang
Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, People’s Republic of China
1 shared publication- Leiying Miao
Department of Cariology and Endodontics, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publication - Menglu Duan
Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, People’s Republic of China
1 shared publication - Shuangshuang Ren
Department of Cariology and Endodontics, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 51, 512-530
NIR-responsive bio-system with sequential antibacterial and immunomodulatory effects for the treatment of periodontitis
In periodontitis, the recurrent bacteria plaque adheres, and intracellular bacteria survival leads to inflammatory immune disorder in periodontal tissue and makes clinical therapeutic outcomes unpredictable. Thoroughly clearing of plaque biofilm and intracellular infectious agents and then regulating the immune environment is a sequential therapy that can match the characteristics of periodontitis. Herein, we construct a near-infrared (NIR)-responsive drug delivery system Hemin@ER-IR808, and investigated its sequential antibacterial and immunomodulatory effects as well as the mechanism in vitro and in vivo. According to the results, NIR laser activated IR808 to produce reactive oxygen species (ROS) to inhibit the proliferation of periodontal bacteria and disrupt the biofilm structure. Then ROS opened the erythrocyte (ER) membrane to release the encapsulated Hemin, which activated the ferroptosis-like stress of intracellular bacteria. Mechanistically, at the early stage of intracellular bacterial infection, Hemin@ER-IR808 ehanced the glycolysis, metabolic reprogramming macrophage to M1-type, which limited the number of intracellular bacteria more than the M2-type; later increased the mitophagy and the level of GPX4, SLC7A11 and HO-1, protecting the macrophage from ferroptosis. In vivo, Hemin@ER-IR808 reduced the number of periodontal flora in rats and alleviated periodontal inflammation. At the later stage, Hemin@ER-IR808 exerted antioxidant effect and promoted the repair of periodontal tissue. In the complex periodontal infectious and inflammatory organizational environment, Hemin@ER-IR808 can emerge as a viable strategy to protect periodontal tissue from reinfection and exert immunomodulatory function to achieve sequential periodontal tissue regeneration.
- 1 September 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 51, 512-530
Open AccessNIR-responsive bio-system with sequential antibacterial and immunomodulatory effects for the treatment of periodontitis
In periodontitis, the recurrent bacteria plaque adheres, and intracellular bacteria survival leads to inflammatory immune disorder in periodontal tissue and makes clinical therapeutic outcomes unpredictable. Thoroughly clearing of plaque biofilm and intracellular infectious agents and then regulating the immune environment is a sequential therapy that can match the characteristics of periodontitis. Herein, we construct a near-infrared (NIR)-responsive drug delivery system Hemin@ER-IR808, and investigated its sequential antibacterial and immunomodulatory effects as well as the mechanism in vitro and in vivo. According to the results, NIR laser activated IR808 to produce reactive oxygen species (ROS) to inhibit the proliferation of periodontal bacteria and disrupt the biofilm structure. Then ROS opened the erythrocyte (ER) membrane to release the encapsulated Hemin, which activated the ferroptosis-like stress of intracellular bacteria. Mechanistically, at the early stage of intracellular bacterial infection, Hemin@ER-IR808 ehanced the glycolysis, metabolic reprogramming macrophage to M1-type, which limited the number of intracellular bacteria more than the M2-type; later increased the mitophagy and the level of GPX4, SLC7A11 and HO-1, protecting the macrophage from ferroptosis. In vivo, Hemin@ER-IR808 reduced the number of periodontal flora in rats and alleviated periodontal inflammation. At the later stage, Hemin@ER-IR808 exerted antioxidant effect and promoted the repair of periodontal tissue. In the complex periodontal infectious and inflammatory organizational environment, Hemin@ER-IR808 can emerge as a viable strategy to protect periodontal tissue from reinfection and exert immunomodulatory function to achieve sequential periodontal tissue regeneration.
- Open Access
- 1 March 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 2917-2938
Electrospun L-Lysine/Amorphous Calcium Phosphate Loaded Core-Sheath Nanofibers for Managing Oral Biofilm Infections and Promoting Periodontal Tissue Repairment
Introduction: Periodontitis, a chronic inflammatory disease prevalent worldwide, is primarily treated through GTR for tissue regeneration. The efficacy of GTR, however, remains uncertain due to potential infections and the intricate microenvironment of periodontal tissue. Herein, We developed a novel core-shell structure multifunctional membrane using a dual-drug-loaded coaxial electrospinning technique (Lys/ACP-CNF), contains L-lysine in the outer layer to aid in controlling biofilms after GTR regenerative surgery, and ACP in the inner layer to enhance osteogenic performance for accelerating alveolar bone repair. Methods: The biocompatibility and cell adhesion were evaluated through CCK-8 and fluorescence imaging, respectively. The antibacterial activity was assessed using a plate counting assay. ALP, ARS, and RT-qPCR were used to examine osteogenic differentiation. Additionally, an in vivo experiment was conducted on a rat model with acute periodontal defect and infection. Micro-CT and histological analysis were utilized to analyze the in vivo alveolar bone regeneration. Results: Structural and physicochemical characterization confirmed the successful construction of the core-shell fibrous structure. Additionally, the Lys/ACP-CNF showed strong antibacterial coaggregation effects and induced osteogenic differentiation of PDLSCs in vitro. The in vivo experiment confirmed that Lys/ACP-CNF promotes new bone formation. Conclusion: Lys/ACP-CNF rapidly exhibited excellent antibacterial activity, protected PDLSCs from infection, and was conducive to osteogenesis, demonstrating its potential application for clinical periodontal GTR surgery.
- 1 March 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 2917-2938
Open AccessElectrospun L-Lysine/Amorphous Calcium Phosphate Loaded Core-Sheath Nanofibers for Managing Oral Biofilm Infections and Promoting Periodontal Tissue Repairment
Introduction: Periodontitis, a chronic inflammatory disease prevalent worldwide, is primarily treated through GTR for tissue regeneration. The efficacy of GTR, however, remains uncertain due to potential infections and the intricate microenvironment of periodontal tissue. Herein, We developed a novel core-shell structure multifunctional membrane using a dual-drug-loaded coaxial electrospinning technique (Lys/ACP-CNF), contains L-lysine in the outer layer to aid in controlling biofilms after GTR regenerative surgery, and ACP in the inner layer to enhance osteogenic performance for accelerating alveolar bone repair. Methods: The biocompatibility and cell adhesion were evaluated through CCK-8 and fluorescence imaging, respectively. The antibacterial activity was assessed using a plate counting assay. ALP, ARS, and RT-qPCR were used to examine osteogenic differentiation. Additionally, an in vivo experiment was conducted on a rat model with acute periodontal defect and infection. Micro-CT and histological analysis were utilized to analyze the in vivo alveolar bone regeneration. Results: Structural and physicochemical characterization confirmed the successful construction of the core-shell fibrous structure. Additionally, the Lys/ACP-CNF showed strong antibacterial coaggregation effects and induced osteogenic differentiation of PDLSCs in vitro. The in vivo experiment confirmed that Lys/ACP-CNF promotes new bone formation. Conclusion: Lys/ACP-CNF rapidly exhibited excellent antibacterial activity, protected PDLSCs from infection, and was conducive to osteogenesis, demonstrating its potential application for clinical periodontal GTR surgery.